Reverse Shoulder Prosthesis Prospective Multi-Center Study
Launched by ENCORE MEDICAL, L.P. · Oct 30, 2009
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Reverse shoulder arthroplasty for the treatment of rotator cuff deficiency and glenohumeral arthritis have shown favorable outcomes in pain and function over the short and medium term. A prospective, multi-center study on the outcomes of subjects treated with the RSP would be a valuable addition to the literature and give important information regarding an ever-increasing treatment option for subjects with rotator cuff deficiency. The study will take place at multiple sites across the United States and will be managed by the DJO Surgical Clinical Affairs Department. The study will include o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject must be a candidate for a total shoulder joint replacement
- * Subject must be diagnosed with one or more of the following conditions:
- • Irreparable rotator cuff tear with gleno-humeral arthritis; Failed rotator cuff surgery with gleno-humeral instability or antero- superior escape; Failed shoulder replacement surgery
- • Subject has a functional deltoid muscle
- • Subject's joint must be anatomically and functionally suited to receive the selected implant
- • Subject is 60 years of age or older (≥ 60 yrs of age) at time of consent
- • Subject is likely to be available for all study visits
- • Subject is able and willing to sign the informed consent and follow study procedures
- • Subject is not pregnant
- Exclusion Criteria:
- • Subject has a non-functional deltoid muscle
- • Subject has a mental condition(s) that may interfere with the subject's ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the Subject cannot understand the informed consent process, global dementia, prior strokes that interfere with the Subject's cognitive abilities, senile dementia, and Alzheimer's Disease)
- • Subject is a prisoner
- • Subject has high levels of physical activity (ex. competitive sports, heavy physical labor)
- • Subject is pregnant
- • Subject has an active infection or sepsis
- • Subject has loss of ligamentous structures
- • Subject has a history of alcoholism or other addictions (current or past)
- • Subject has muscular, neurological or vascular deficiencies which compromise the affected extremity (i.e., Parkinson's Disease, Syringomyelia and Multiple Sclerosis, Charcot joints)
- • Subject has severe glenoid bone loss
- • Subject has known materials sensitivity (to metals)
- • Subject is younger than 60 years of age (\< 60 years of age) at consent
About Encore Medical, L.P.
Encore Medical, L.P. is a leading medical device company dedicated to advancing orthopedic and surgical solutions through innovative research and development. With a focus on enhancing patient outcomes and improving procedural efficiencies, Encore Medical specializes in a diverse range of products, including implants and instrumentation designed for joint reconstruction and trauma management. The company is committed to conducting rigorous clinical trials to validate the safety and efficacy of its offerings, ensuring compliance with regulatory standards while fostering collaboration with healthcare professionals. Through its dedication to innovation and quality, Encore Medical aims to transform the landscape of orthopedic care and enhance the lives of patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Danville, Pennsylvania, United States
Plano, Texas, United States
Bradenton, Florida, United States
Saint George, Utah, United States
Redwood City, California, United States
Fort Lauderdale, Florida, United States
Louisville, Kentucky, United States
Amherst, New York, United States
Cincinnati, Ohio, United States
Patients applied
Trial Officials
Samer S. Hasan, M.D.
Principal Investigator
Cincinnati Sports Medicine and Orthopaedic Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials